Volume 8, Issue 26 (3-2002)
RJMS 2002, 8(26): 411-413 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Haghighi L, Rahmani E. INDOMETHACIN THERAPY IN SEVERE POLYHYDRAMNIOS. RJMS 2002; 8 (26) :411-413
URL: http://rjms.iums.ac.ir/article-1-378-en.html
URL: http://rjms.iums.ac.ir/article-1-378-en.html
Abstract: (10042 Views)
Polyhydramnios is defined as excessive accumulation of amniotic fluid. It is associated with inceased incidence of abruptio placenta, preterm birth, cord prolopse and neonatal death (30%). So in this clinical trial, 12 pregnant women with significant polyhydramnios (AFI> 24 cm) and gestational age of 24-32 weeks, received oral Indomethacin at a dose of 100 mg/day for 8 days. AF volume decreased in all patients (P=0.000). We didn’t observe any maternal and fetal-neonatal side effect due to indomethacin therapy. Mean gestational age at delivery was 37.7 ± 1 weeks. It can be concluded that short term indomethacin therapy is effective in significant polyhydramnios without any maternal and fetal side effect.
Type of Study: Research |
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
